VanEck Pharmaceutical ETF
PPH
#1226
ETF rank
โ‚น95.63 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
โ‚น9,672
Share price
-0.72%
Change (1 day)
36.55%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of April 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of April 2026: 0.36%